Research Reports published by STOXBOX - BP WEALTH

Name: Latest research reports of Nazara Technologies Ltd. authored by StoxBox - BP Wealth and published by - Trendlyne research reports.
Item: Nazara Technologies Ltd.
Rating: 5
Author: StoxBox - BP Wealth

Latest research reports published by Stoxbox - BP Wealth

Nazara Technologies Ltd.

24 Aug 2023, 12:00AM

956.25

-0.96%

Technical View

Buy: Nazara Technologies Ltd.

StoxBox - BP Wealth

The pattern analysis on the weekly timeframe shows that the price action has entered into its stage 2 following a brief consolidation phase. The lateral trend following a 71% decline is a potential sign of accumulation and an indication that the drawdowns were finally arrested.

Nazara Technologies .. has an average target of 1131.00 from 2 brokers.

Carysil Ltd.

17 Aug 2023

640.65

-4.98%

Result Update

Results Update: Carysil Ltd.

StoxBox - BP Wealth

In Q1FY24, Carysil Ltd. reported a revenue decline of 2.7% QoQ / 17.3% YoY to Rs. 171.3 crores in Q1FY24 owing to lower production and sales due to SAP implementation in April 2023, thus missing market expectations of Rs. 160.2 crores. On a sequential basis, the GP and EBITDA margins improved 176 bps / 38 bps to 49.9% and 18.4%, respectively, with the normalization in freight and other input costs of the business which outweighed an uptick in employee expenses.

Carysil Ltd. has gained 15.62% in the last 1 Month

Shree Digvijay Cement Company Ltd.

03 Aug 2023

70.40

-1.46%

Core Investor Series

Buy: Shree Digvijay Cement Comp...

StoxBox - BP Wealth

Shree Digvijay Cement Company Ltd. stands strong for the past seven decades, carving out the long proud legacy of building the nation by manufacturing superior quality cement. Today, it is one of the most experienced cement-producing companies in India.

Shree Digvijay Cement Company Ltd. has lost -28.27% in the last 1 Year

Marksans Pharma Ltd.

22 Jul 2023

226.00

-0.93%

Strong growth in OTC business to drive profitability

Buy: Marksans Pharma Ltd.

StoxBox - BP Wealth

Marksans Pharma has entered into a Business Transfer Agreement with Tevapharm to acquire its business relating to the manufacture and supply of bulk pharmaceutical formulations in Goa. The company plans to manufacture tablets, hard and soft gel capsules, ointments, gummies, and creams from the new capacity.

Number of FII/FPI investors increased from 125 to 149 in Dec 2024 qtr.

CCL Products India Ltd.

18 Jul 2023

575.25

-1.19%

Volume growth intact; Increasing debt levels a key monitorable

Buy: CCL Products India Ltd.

StoxBox - BP Wealth

CCL Products (India) Ltd. (CCLP) registered a 28.6% YoY revenue growth to Rs. 654.9 crores in Q1FY24, surpassing market expectations of Rs. 580.1 crores, led by the company maintaining its volume-driven growth trajectory in the 18-20% range with additional volumes driven by the Vietnam plant.

CCL Products India Ltd. is trading below all available SMAs

Trading Strategy

TREND | 12 Jul 2023

Techno Funda Report – JULY 2023

Trading Strategy

StoxBox - BP Wealth

Devyani International (DIL) has demonstrated strong growth momentum and has crossed significant milestones in terms of revenue of Rs. 3,000 crores backed by store additions across brands and continued healthy performance from its existing stores.

Escorts Kubota Ltd.

07 Jul 2023

3212.45

-1.82%

Special Report

Buy: Escorts Kubota Ltd.

StoxBox - BP Wealth

The total tractor industry volume, domestic and exports, in FY23 went up by 10.2% to 10.7 lakh units compared to 9.7 lakh units in FY22. This is a new record for the tractor industry, beating the last peak of 9.88 lakh units in FY21. The domestic tractor industry went up by 12.2% to a record 9.45 lakh units in FY23 compared to 8.4 lakh units in FY22.

Escorts Kubota Ltd. is trading below its 100 day SMA of 3333.5

PKH Ventures Ltd.

28 Jun 2023

Diversified business model helps in cushioning business performance during downtimes

IPO Avoid: PKH Ventures Ltd.

StoxBox - BP Wealth

PKH Ventures are in the business of Construction & Development, Hospitality and Management Ser- vices. The company’s businesses generate income from diverse activities completely independent of each other.

Torrent Pharmaceuticals Ltd.

01 Jun 2023

3245.05

-0.81%

Robust growth across key markets

Results Update: Torrent Pharmaceuticals Ltd.

StoxBox - BP Wealth

Torrent Pharma reported a revenue growth of 16.9% YoY / flat QoQ to Rs. 24,910 mn and was marginally above market expectations of Rs. 24,320 mn. Domestic revenue grew 21.6% YoY, aided by strong performance of new launches in chronic therapies and integration of Curatio.

Torrent Pharmaceutic.. has an average target of 3522.40 from 6 brokers.

City Union Bank Ltd.

31 May 2023

158.55

-0.18%

City Union Bank (CUBK) reported a weak performance in Q4FY23, with the outlook remaining tepid for the first half of FY24

Results Update: City Union Bank Ltd.

StoxBox - BP Wealth

CUBK earned Net Interest Income of Rs.514.3 crores for Q4FY23 as against Rs.500.7 crores in Q4FY22. For FY23, the NII increased by 13% and stood at Rs. 2,163.0 crores as against Rs. 1,916.0 crores for the last financial year. The bank’s NIM declined to 3.65% in Q4FY23 from 3.88% in Q3FY23 and 4.01% in Q4FY22.

City Union Bank Ltd. is trading above its 30 day SMA of 155.5

No results found